Skip to content

12-Week-Combined Physical Training In Heart Failure Patients

Impact Of Supervised 12-Week-Combined Physical Training In Heart Failure Patients: A Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02571270
Enrollment
28
Registered
2015-10-08
Start date
2015-03-31
Completion date
Unknown
Last updated
2015-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure Patients

Keywords

Exercise, quality of life, healthy, cardiac remodeling

Brief summary

Purpose: Physical exercise exerts favorable impact on functional capacity (FC) and quality of life (QL) in patients with heart failure (HF). It is believed that the combined aerobic and resistance physical training (CPT) supervised by physical educator is better than only prescription of unsupervised exercise. The aim of this study is to compare the effects of a CPT program on the FC and QL of HF patients with reduced ejection fraction (HFREF) with the practice medical routine prescription of regular physical activity and correlate these findings with clinical and echocardiographic variables. Methods: A longitudinal prospective study included 28 consecutive HFREF patients randomly divided in two age- and gender- matched groups: Trained Group (TG, n = 17), patients undergoing 12 weeks of supervised CPT and Non Trained Group (NTG, n = 11), patients receiving only medical prescription to practice regular physical exercise. All patients were submitted to clinical evaluation, transthoracic echocardiography, Cooper walk test and QL questionnaire before and after the study protocol. Student t test or Mann-Whitney test were performed for groups comparison and correlation tests for the same group variable associations.

Interventions

OTHERCombined aerobic and resistance physical training program

Sponsors

Universidade Estadual Paulista Júlio de Mesquita Filho
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with heart failure with LVEF \<50%; * Patients with optimized drug therapy; * Age over 18 years.

Exclusion criteria

* Heart failure NYHA class IV and/or Stage D; * Decompensated HF in the last three months; * Atrial fibrillation and/or implantable device at the moment of inclusion; * Patients with chronic obstructive pulmonary disease (COPD); * Patients with biomechanical limitations of physical activity.

Design outcomes

Primary

MeasureTime frame
Diastolic Function echocardiographic variables (cm/s)up to 12 weeks of research
Questionnaire about quality of lifeup to 12 weeks of research
Cardiorespiratory evaluation (VO2 in Mets)up to 12 weeks of research
Morphological echocardiographic variables (mm)up to 12 weeks of research
Sistolic Function echocardiographic variables (Percentage)up to 12 weeks of research

Secondary

MeasureTime frame
Body composition (%fat percentage)up to 12 weeks of research
Presence of comorbiditiesup to 12 weeks of research
Blood pressure measurement (mmHg)up to 12 weeks of research
Anthropometric measurements (cm)up to 12 weeks of research

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026